Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

711
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
711
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

686
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
686
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

835
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
835
T Cell Types and Functions01:24

T Cell Types and Functions

1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

679
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
679
Inflammatory Response01:28

Inflammatory Response

12.2K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative Efficacy of Seven Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Network Meta-Analysis.

Allergy·2026
Same author

Circulating Type 2 Memory B Cell Frequency Is a Biomarker for Allergen Immunotherapy Efficacy in Patients With Allergic Rhinitis.

Allergy·2026
Same author

Synergistic Effect Evaluation and Mechanism Investigation of Vitamin B6 and B12 in Models of Neuroinflammation.

International journal of molecular sciences·2025
Same author

Single-Cell Profiling Identifies TNF-Responsive Circulating Eosinophils in Allergic Rhinitis.

Allergy·2025
Same author

Interleukin-31 in Respiratory Type 2 Inflammatory Diseases: Mechanistic Insights and Therapeutic Potential.

Journal of inflammation research·2025
Same author

[Chinese expert consensus on the evaluation of allergen-specific immunotherapy outcomes（Wuhan, 2025）].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2025

Related Experiment Video

Updated: Oct 17, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.0K

[Neuroimmunomodulation in allergic rhinitis].

Shiru Cai, Hongfei Lou

    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery
    |October 11, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Neuroimmunomodulation significantly impacts allergic rhinitis (AR). Understanding neuro-immune signaling in AR offers new therapeutic targets for this common allergic disease.

    Keywords:
    nasal hyperresponsivenessneuroimmunomodulationneuropeptidesrhinitis, allergic

    More Related Videos

    Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
    03:40

    Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

    Published on: December 20, 2024

    780
    Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
    11:54

    Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

    Published on: January 21, 2018

    31.1K

    Related Experiment Videos

    Last Updated: Oct 17, 2025

    Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
    06:08

    Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

    Published on: September 22, 2023

    2.0K
    Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
    03:40

    Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

    Published on: December 20, 2024

    780
    Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
    11:54

    Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

    Published on: January 21, 2018

    31.1K

    Area of Science:

    • * Neuroscience
    • * Immunology
    • * Allergic Diseases

    Background:

    • * Allergic rhinitis (AR) involves an overactive immune response in the nasal mucosa.
    • * Immune cells release mediators that activate peripheral neurons, causing AR symptoms like sneezing and congestion.
    • * Peripheral neurons release neurotransmitters and neuropeptides that exacerbate allergic inflammation.

    Purpose of the Study:

    • * To explore the role of neuroimmunomodulation in allergic diseases.
    • * To understand the cellular and molecular interactions between the nervous and immune systems in AR.
    • * To identify potential new therapeutic targets for AR.

    Main Methods:

    • * Review of recent research on neuroimmunomodulation in allergic diseases.
    • * Analysis of signaling pathways involving immune mediators, neurotransmitters, and neuropeptides.
    • * Examination of the pathophysiology of allergic rhinitis.

    Main Results:

    • * Neuro-immune signaling is a critical component in the pathophysiology of AR.
    • * A bidirectional communication exists between immune cells and peripheral neurons in AR.
    • * Inflammatory mediators and neurotransmitters play key roles in AR symptoms and inflammation.

    Conclusions:

    • * Neuro-immune interactions are central to allergic rhinitis.
    • * Further understanding of these pathways can lead to novel therapeutic strategies.
    • * Targeting neuro-immune signaling may provide new treatments for allergic rhinitis.